You are here

Article Text

Article menu

Download PDFPDF

Correspondence
Application of MS score in macrophage activation syndrome patients associated with adult onset Still’s disease
Free
  1. Ran Wang1,
  2. Ting Li2,
  3. Shuang Ye2,
  4. Wenefng Tan3,
  5. Cheng Zhao4,
  6. Yisha Li5,
  7. Chunde Bao1,
  8. Qiong Fu1
  1. 1 Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital, Shanghai, China
  2. 2 Department of Rheumatology, Shanghai Jiao Tong University School of Medicine Affiliated Renji Hospital South Campus, Shanghai, China
  3. 3 Department of Rheumatology, The First Affiliate Hospital of Nanjing Medical University, Nanjing, China
  4. 4 Department of Rheumatology, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, Nanjing, China
  5. 5 Department of Rheumatology, Xiangya Hospital of Central South University, Changsha, China
  1. Correspondence to Dr Qiong Fu, Department of Rheumatology, Shanghai Jiao Tong University School of Medicine, Affiliated Renji Hospital, Shanghai, China; fuqiong5{at}163.com

https://doi.org/10.1136/annrheumdis-2019-216286

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the article by Minoia et al which named development and initial validation of the macrophage activation syndrome (MAS)/systemic juvenile idiopathic arthritis (sJIA) (MS) score for diagnosis of MAS in sJIA.

    MAS is a life-threatening complication of rheumatic disorders, including sJIA, adult-onset Still’s disease (AOSD) and lupus.1–4 Timely diagnosis and appropriate treatment of MAS are particularly important to improve the prognosis of MAS patients. At present, hemophagocytic lymphohistiocytosis (HLH)-2004 and HLH-2009 criteria are widely used to identify MAS associated with AOSD. Hemophagocytic syndrome diagnostic (HS) score was developed previously to facilitate MAS recognition, but still requires validation.5 In 2019, Francesca Minoia et al reported a MS score for classification of sJIA-associated MAS patients.6 Considering that sJIA and AOSD are thought to constitute …

    View Full Text

    Linked Articles